Subsequent to CGA administration, substantial reductions emerged in the levels of these indicators relative to the ARDS cohort, particularly evident for PAD4 alongside citH3 (p < 0.01) and MPO (p < 0.0001), as depicted in Figure 3(B–C). The gene discussed is MPO; the disease is acute respiratory distress syndrome.